In this newsletter we talk about two of our investees:
- Hatchtech and Dr. Reddy’s Laboratories sign US$197 million commercial agreement for next generation head lice treatment
- Uniseed investee ProGel Pty Ltd releases Perkii® probiotic drink.
Uniseed Newsletter – September 2015
